Cascadian Therapeutics Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

CASC 5.55 +0.05 (0.91%)
price chart
Today's Pattern Alert: Could Cascadian Therapeutics Inc (USA) Decrease Even ...
The stock of Cascadian Therapeutics Inc (USA) (CASC) shows a multiple bottoms pattern with $5.20 target or 7.00% below today's $5.59 share price.
Hot News: Patterson-UTI Energy Inc. (NASDAQ:PTEN), Cascadian Therapeutics ...  Benchmark Monitor
Brokerage Firm Target Review on Cascadian Therapeutics Inc (USA) (NYSE:CASC)
Let's take a brief check on where covering Street analysts see Cascadian Therapeutics Inc (USA) (NYSE:CASC) moving in the near-term.
Trade: Today, Cascadian Therapeutics Inc. (CASC) Rating Increased to Hold at ...  DailyQuint
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) Likely to Breakout
Investors should take note of the 14% jump in the share price of Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) yesterday on a traded volume of 2.01 million shares.
Cascadian Therapeutics, Inc. (NASDAQ:CASC) Insiders Look Optimistic About ...  Review Fortune
Stock Pattern: Does This Provide a Reason to Sell Cascadian Therapeutics Inc ...
The chart of Cascadian Therapeutics Inc (USA) (CASC) shows a double bottom with $0.92 target or 8.00% below today's $1.00 share price.
Cascadian Therapeutics Inc. (CASC) Upgraded to Hold by Zacks Investment Research  The Cerbat Gem
Follow The Short Interest: Time to Reconsider Cascadian Therapeutics ...  Post News
Stock Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Announces ...
casc Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) announced that its board of directors has approved a plan for a reverse split of the Company's common stock to increase its share price and reduce the number of authorized and outstanding shares.
Cascadian Therapeutics Announces Stockholders and Board of Directors Approve ...
23, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that at a special meeting held on November 18, 2016, stockholders voted to approve a proposal authorizing the board of ...
Cascadian Therapeutics (CASC) Approves 1-for-6 Reverse Stock Split  StreetInsider.com
Notable Chart Action: Is Selling Stock Like Cascadian Therapeutics Inc (USA ...
The chart of Cascadian Therapeutics Inc (USA) (CASC) shows a double bottom with $0.87 target or 11.00% below today's $0.97 share price.
Cascadian Therapeutics Inc. (CASC) Earns Buy Rating from Jefferies Group  Community Financial News
Cascadian Therapeutics Reports Third Quarter 2016 Financial Results and ...  GlobeNewswire (press release)
Stock Overbuying Recap: Cascadian Therapeutics Inc (USA) (NASDAQ:CASC)
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) share price soared 3.77% or +0.06 points to reach at $1.65 during previous trading session.
Recent analysts Ratings: Cascadian Therapeutics, Inc. (NASDAQ:CASC)  News Oracle
Stock Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Receives ONT-380 ...
Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic breast cancer has received Fast Track designation from the U.S. Food and Drug ...
Company Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Announces ...
casc Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
Cascadian Therapeutics Prices $41.8 Million Concurrent Offerings of Common ...  Virtual-Strategy Magazine